Advertisement
CNO vs FG
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNO is a Hold and FG is a Buy.
CNO in downward trend: price expected to drop as it breaks its higher Bollinger Band on October 30, 2026
CNO broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 37 similar instances where the stock broke above the upper band. In 22 of the 37 cases the stock fell afterwards. This puts the odds of success at 59%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for CNO moved out of overbought territory on November 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 22 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 54%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 31 of 68 cases where CNO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 46%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on CNO as a result. In 54 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.
The Moving Average Convergence Divergence (MACD) for CNO just turned positive on October 15, 2026. Looking at past instances where CNO's MACD turned positive, the stock continued to rise in 29 of 47 cases over the following month. The odds of a continued upward trend are 62%.
CNO moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CNO crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.
Following a +6.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNO advanced for three days, in 207 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 184 of 296 cases where CNO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.980) is normal, around the industry mean (1.342). P/E Ratio (18.733) is within average values for comparable stocks, (19.865). Projected Growth (PEG Ratio) (0.210) is also within normal values, averaging (0.463). Dividend Yield (0.013) settles around the average of (0.047) among similar stocks. P/S Ratio (1.156) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
FG in upward trend: price rose above 50-day moving average on November 06, 2026
FG moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend. In 25 of 31 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on FG as a result. In 53 of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for FG just turned positive on October 19, 2026. Looking at past instances where FG's MACD turned positive, the stock continued to rise in 23 of 35 cases over the following month. The odds of a continued upward trend are 66%.
Following a +3.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where FG advanced for three days, in 179 of 246 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.
FG broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for FG entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.664) is normal, around the industry mean (1.342). P/E Ratio (7.666) is within average values for comparable stocks, (19.865). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (0.463). Dividend Yield (0.043) settles around the average of (0.047) among similar stocks. P/S Ratio (0.534) is also within normal values, averaging (1.303).
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. FG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock slightly worse than average.
The Tickeron Seasonality Score of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 86 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CNO | FG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 45 | 20 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 61 Fair valued | 21 Undervalued | |
PROFIT vs RISK RATING 1..100 | 4 | 62 | |
SMR RATING 1..100 | 94 | 94 | |
PRICE GROWTH RATING 1..100 | 41 | 61 | |
P/E GROWTH RATING 1..100 | 13 | 86 | |
SEASONALITY SCORE 1..100 | 50 | 70 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FG's Valuation (21) in the Life Or Health Insurance industry is somewhat better than the same rating for CNO (61). This means that FG’s stock grew somewhat faster than CNO’s over the last 12 months.
CNO's Profit vs Risk Rating (4) in the Life Or Health Insurance industry is somewhat better than the same rating for FG (62). This means that CNO’s stock grew somewhat faster than FG’s over the last 12 months.
CNO's SMR Rating (94) in the Life Or Health Insurance industry is in the same range as FG (94). This means that CNO’s stock grew similarly to FG’s over the last 12 months.
CNO's Price Growth Rating (41) in the Life Or Health Insurance industry is in the same range as FG (61). This means that CNO’s stock grew similarly to FG’s over the last 12 months.
CNO's P/E Growth Rating (13) in the Life Or Health Insurance industry is significantly better than the same rating for FG (86). This means that CNO’s stock grew significantly faster than FG’s over the last 12 months.
| CNO | FG | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 54% | 2 days ago 71% |
| Stochastic ODDS (%) | 2 days ago 46% | 2 days ago 78% |
| Momentum ODDS (%) | 2 days ago 63% | 2 days ago 74% |
| MACD ODDS (%) | 2 days ago 62% | 2 days ago 66% |
| TrendWeek ODDS (%) | 2 days ago 45% | 2 days ago 73% |
| TrendMonth ODDS (%) | 2 days ago 61% | 2 days ago 72% |
| Advances ODDS (%) | 6 days ago 63% | 6 days ago 73% |
| Declines ODDS (%) | 2 days ago 46% | 13 days ago 68% |
| BollingerBands ODDS (%) | 2 days ago 59% | 2 days ago 82% |
| Aroon ODDS (%) | 2 days ago 62% | 2 days ago 69% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNO’s FA Score shows that 2 FA rating(s) are green while FG’s FA Score has 1 green FA rating(s).
- CNO’s FA Score: 2 green, 3 red.
- FG’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNO’s TA Score shows that 6 TA indicator(s) are bullish while FG’s TA Score has 4 bullish TA indicator(s).
- CNO’s TA Score: 6 bullish, 4 bearish.
- FG’s TA Score: 4 bullish, 5 bearish.
Price Growth
CNO (@Life/Health Insurance) experienced а -3.85% price change this week, while FG (@Life/Health Insurance) price change was +10.65% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.42%. For the same industry, the average monthly price growth was +0.46%, and the average quarterly price growth was -4.03%.
Reported Earning Dates
CNO is expected to report earnings on Feb 09, 2027.
Industries' Descriptions
@Life/Health Insurance (+0.42% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
Advertisement
CNO and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNO has been loosely correlated with LNC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CNO jumps, then LNC could also see price increases.
FG and
Correlation & Price change
A.I.dvisor indicates that over the last year, FG has been loosely correlated with LNC. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if FG jumps, then LNC could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| REMX | 51.40 | 0.87 | +1.72% |
| VanEck Rare Earth and Strategic Metals ETF (REMX) | |||
| DVSP | 27.48 | 0.09 | +0.35% |
| WEBs SPY Defined Volatility ETF (DVSP) | |||
| DDFD | 20.26 | 0.06 | +0.28% |
| Innovator Equity Dual Directional 15 Buffer ETF - December (DDFD) | |||
| CBIL | 24.85 | N/A | N/A |
| Corgi 3-12 Month T-Bill ETF (CBIL) | |||
| TPLC | 50.15 | -0.22 | -0.44% |
| Timothy Plan US Large/Mid Cap Core ETF (TPLC) | |||